# Alkermes plc. (ALKS) · Edgar & Edgarette company card

> Alkermes (ALKS) saw revenue fall 5.2% in FY2025 to $1.5 billion, operating margin 17.2% against a -3.8% median for pharmaceutical preparations, equity 73.2% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1520262 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/ALKS) · [JSON](https://www.pops4.com/boards/company/ALKS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1.5B |
| Revenue growth, 1 year | -5.2% |
| Revenue growth per year | 5.9% |
| Operating margin | 17.2% (prior year 27.0%) |
| Net margin | 16.4% |
| Operating cash flow | $521M |
| Capital spending | $40M |
| Free cash flow | $480M |
| Cash | $389M |
| Long-term debt | — |
| Total assets | $2.5B |
| Total equity | $1.8B |
| Equity ÷ assets | 73.2% |
| Return on equity | 13.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 6.24 (safe zone)
- Piotroski F: 7 of 9 (solid)
- Beneish M: -3.3 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · revenue is hard to predict: its 80% range is ±26%
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $1.5B (FY2025). Experience: revenue down 5.2% on the year, up 5.9% a year over 4 years; operating margin 17.2%, down from 27.0%. Soundness: equity 73.2% of assets, return on equity 13.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.1B and $1.9B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $937.8M to $2.3B. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin 17.2% against a -3.8% median; growth -5.2% against 13.7%.

Range logged 2026-09-24, receipt 4c7c9ba8c9e0a119, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-09-16 ([filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526392527/0001193125-26-392527-index.htm))

## Recent filings

- 10-Q · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526444507/0001193125-26-444507-index.htm)
- 8-K · filed 2026-11-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526444381/0001193125-26-444381-index.htm)
- 8-K · filed 2026-09-21 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526396065/0001193125-26-396065-index.htm)
- 8-K · filed 2026-09-16 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526392527/0001193125-26-392527-index.htm)
- 8-K · filed 2026-08-12 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526345901/0001193125-26-345901-index.htm)
- 10-Q · filed 2026-07-28 · [filing](https://www.sec.gov/Archives/edgar/data/1520262/000119312526319022/0001193125-26-319022-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001520262.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1520262

## Cite

POPS4, Edgar & Edgarette: Alkermes plc. (ALKS) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/ALKS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.